Functional imaging in phase I studies: Decorations or decision making?

被引：30

作者：

Collins, JM ^{[1
]}

机构：

[1] US FDA, Lab Clin Pharmacol, Rockville, MD 20857 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2003年 / 21卷 / 15期

关键词：

D O I：

10.1200/JCO.2003.05.100

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2807 / 2809

页数：3

共 10 条

[1] Assessment of pharmacodynamic vascular response in a phase I trial of combretastatin A4 phosphate [J].

Anderson, HL ;

Yap, JT ;

Miller, MP ;

Robbins, A ;

Jones, T ;

Price, PM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2823-2830

[2]

Dowlati A, 2002, CANCER RES, V62, P3408

[3] Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily [J].

Eder, JP ;

Supko, JG ;

Clark, JW ;

Puchalski, TA ;

Garcia-Carbonero, R ;

Ryan, DP ;

Shulman, LN ;

Proper, J ;

Kirvan, M ;

Rattner, B ;

Connors, S ;

Keogan, MT ;

Janicek, MJ ;

Fogler, WE ;

Schnipper, L ;

Kinchla, N ;

Sidor, C ;

Phillips, E ;

Folkman, J ;

Kufe, DW .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3772-3784

[4] Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging [J].

Galbraith, SM ;

Maxwell, RJ ;

Lodge, MA ;

Tozer, GM ;

Wilson, J ;

Taylor, NJ ;

Stirling, JJ ;

Sena, L ;

Padhani, AR ;

Rustin, GJS .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2831-2842

[5] Phase I study of recombinant human endostatin in patients with advanced solid tumors [J].

Herbst, RS ;

Hess, KR ;

Tran, HT ;

Tseng, JE ;

Mullani, NA ;

Charnsangavej, C ;

Madden, T ;

Davis, DW ;

McConkey, DJ ;

O'Reilly, MS ;

Ellis, LM ;

Pluda, J ;

Hong, WK ;

Abbruzzese, JL .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) :3792-3803

[6] Phase I clinical trial of weekly combretastatin A4 phosphate: Clinical and pharmacokinetic results [J].

Rustin, GJS ;

Galbraith, SM ;

Anderson, H ;

Stratford, M ;

Folkes, LK ;

Sena, L ;

Gumbrell, L ;

Price, PM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2815-2822

[7]

Stephenson J., 2000, Proc. Am. Assoc. Cancer Res, V41

[8] Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors [J].

Thomas, JP ;

Arzoomanian, RZ ;

Alberti, D ;

Marnocha, R ;

Lee, F ;

Friedl, A ;

Tutsch, K ;

Dresen, A ;

Geiger, P ;

Pluda, J ;

Fogler, W ;

Schiller, JH ;

Wilding, G .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :223-231

[9]

Thorpe Philip E., 2003, Cancer Research, V63, P1144

[10]

Tozer GM, 1999, CANCER RES, V59, P1626

← 1 →